Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SGT | SAD SAD DAY for me | 08/11/23 | 1 | 2.1K | |||
|
|||||||
SGT | So what now | 07/05/17 | 2 | 4.2K | |||
|
|||||||
SGT | Ann: Removal from the Official List at close 05/06/15 | 05/06/15 | 0 | 1.5K | |||
|
|||||||
SGT | Ann: Top 20 holders | 04/06/15 | 0 | 1.3K | |||
|
|||||||
SGT | Ann: Appendix 3B | 04/06/15 | 0 | 1.4K | |||
|
|||||||
SGT | Ann: Singtel Investor Day 2015 - Associates | 04/06/15 | 0 | 1.7K | |||
|
|||||||
SGT | Ann: Singtel Investor Day 2015 - Business Units | 04/06/15 | 0 | 1.4K | |||
|
|||||||
SGT | Ann: Suspension from Official Quotation cob 29/05/2015 | 29/05/15 | 0 | 1.1K | |||
|
See All Discussions